MAB8152
Anti-West Nile Virus/Kunjin Antibody, NS1, clone 3.1112G
ascites fluid, clone 3.1112G, Chemicon®
Sign In to View Organizational & Contract Pricing.
Select a Size
All Photos(1)
About This Item
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Product Name
Anti-West Nile Virus/Kunjin Antibody, NS1, clone 3.1112G, ascites fluid, clone 3.1112G, Chemicon®
biological source
mouse
antibody form
ascites fluid
antibody product type
primary antibodies
clone
3.1112G, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable
isotype
IgM
shipped in
wet ice
Analysis Note
Control
West Nile Virus positive patient sample
West Nile Virus positive patient sample
Application
Immunofluorescence: 1:2 to 1:50
EIA 1:20 to 1:200
Western Blot 1:20 to 1:200
Immunohistochemistry
Optimal working dilutions must be determined by the end user.
EIA 1:20 to 1:200
Western Blot 1:20 to 1:200
Immunohistochemistry
Optimal working dilutions must be determined by the end user.
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
This Anti-West Nile Virus/Kunjin Antibody, NS1, clone 3.1112G is validated for use in ELISA, IF, IH, WB for the detection of West Nile Virus/Kunjin.
Biochem/physiol Actions
Specific for the non-structural protein 1 of West Nile/Kunjin virus. Kunjin (KUN) is very closely related to some strains of West Nile virus, and has been classified as a subtype of West Nile.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Immunogen
Epitope: NS1
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Physical form
Ascites fluid with 0.1% sodium azide as a preservative.
Unpurified
Preparation Note
Maintain for 2 years at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Not finding the right product?
Try our Product Selector Tool.
Storage Class
10 - Combustible liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
M Giel-Moloney et al.
Scientific reports, 9(1), 20005-20005 (2019-12-29)
Multiple approaches utilizing viral and DNA vectors have shown promise in the development of an effective vaccine against HIV. In this study, an alternative replication-defective flavivirus vector, RepliVax (RV), was evaluated for the delivery of HIV-1 immunogens. Recombinant RV-HIV viruses
Nadin N Thompson et al.
Vector borne and zoonotic diseases (Larchmont, N.Y.), 12(11), 969-978 (2012-09-20)
Seroprevalence rates of selected arboviruses in animal populations in Trinidad were determined using serum samples collected between 2006 and 2009 from horses (n=506), cattle (n=163), sheep (n=198), goats (n=82), pigs (n=184), birds (n=140), rodents (n=116), and other vertebrates (n=23). The
B Durand et al.
Epidemiology and infection, 144(9), 1857-1864 (2016-02-04)
A serosurvey of 349 military working horses and 231 military working dogs was conducted in ten sites in Morocco in 2012. This survey revealed a high level of exposure of these animals to flaviviruses: seroprevalence rates of 60% in horses
Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness.
Melissa C Whiteman,Jason A Wicker,Richard M Kinney,Claire Y-H Huang,Tom Solomon,Alan D T Barrett
Vaccine null
M A Loroño-Pino et al.
Clinical and vaccine immunology : CVI, 16(5), 749-755 (2009-03-27)
An epitope-blocking enzyme-linked immunosorbent assay (b-ELISA) was evaluated for the diagnosis of West Nile virus (WNV) infections in humans. Sera from patients diagnosed with WNV infections from an outbreak in 2003 in Colorado and from patients diagnosed with dengue virus
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service